Loading...
OTCM
PFND
Market cap66kUSD
Nov 03, Last price  
0.00USD
Name

Pathfinder Cell Therapy Inc

Chart & Performance

D1W1MN
OTCM:PFND chart
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0k
-100.00%
1,201,00058,00035,0000000142,000134,000181,000360,000344,00073,000114,00054,0000
Net income
-2m
L-7.84%
-955,000-520,000-728,000-1,048,000-1,577,000-1,841,000-2,148,000-3,895,000-4,623,000-4,404,000-4,103,000-2,076,000-18,922,000-2,252,000-1,811,000-1,669,000
CFO
-963k
L-39.85%
-523,000-441,000-905,000-905,000-1,310,000-1,504,000-1,922,000-2,669,000-3,582,000-3,887,000-3,648,000-1,290,000-2,330,000-2,024,000-1,601,000-963,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in regenerative medicine. This company is dedicated to pioneering innovative cell-based and associated treatments designed to address a range of illnesses and health issues, particularly those involving localized cellular injury within organs. Its proprietary technology shows promise for tackling conditions such as diabetes, kidney disease, heart attacks (myocardial infarction), and peripheral vascular ailments, among others. Established in 2008, the company maintains its corporate headquarters in Cambridge, Massachusetts.
URL
http://www.pathfindercelltherapy.com/
IPO date
Sep 22, 1992
Employees
Domiciled in
US
Incorporated in
US

Valuation

No data to show